Atai Life Sciences Total Liabilities 2020-2025 | ATAI

Atai Life Sciences total liabilities from 2020 to 2025. Total liabilities can be defined as the total value of all possible claims against the corporation.
Atai Life Sciences Annual Total Liabilities
(Millions of US $)
2024 $43
2023 $49
2022 $40
2021 $28
2020 $16
2019 $2
Atai Life Sciences Quarterly Total Liabilities
(Millions of US $)
2025-03-31 $44
2024-12-31 $43
2024-09-30 $51
2024-06-30 $47
2024-03-31 $46
2023-12-31 $49
2023-09-30 $40
2023-06-30 $38
2023-03-31 $40
2022-12-31 $40
2022-09-30 $47
2022-06-30 $29
2022-03-31 $29
2021-12-31 $28
2021-09-30 $21
2021-06-30 $21
2021-03-31 $25
2020-12-31 $16
2020-09-30 $0
2020-06-30 $0
2020-03-31 $0
2019-12-31 $2
Sector Industry Market Cap Revenue
Medical Medical - Outpatient & Home Care $0.663B $0.000B
atai Life Sciences B.V. is a clinical-stage biopharmaceutical company aiming to transform the treatment of mental health disorders. atai Life Sciences B.V. is based in BERLIN.
Stock Name Country Market Cap PE Ratio
Quest Diagnostics (DGX) United States $18.779B 17.94
DaVita (DVA) United States $11.021B 15.50
Encompass Health (EHC) United States $10.912B 23.13
Elanco Animal Health (ELAN) United States $7.147B 15.31
Chemed (CHE) United States $6.798B 22.68
Option Care Health (OPCH) United States $4.934B 21.99
RadNet (RDNT) United States $4.242B 269.24
Amedisys (AMED) United States $3.201B 20.53
Addus HomeCare (ADUS) United States $1.985B 21.80
LifeStance Health (LFST) United States $1.606B 0.00
Astrana Health (ASTH) United States $1.314B 32.54
U.S Physical Therapy (USPH) United States $1.149B 29.66
Pennant (PNTG) United States $0.792B 29.09
Aveanna Healthcare Holdings (AVAH) United States $0.784B 44.67
Daxor (DXR) United States $0.050B 0.00
MEDIROM Healthcare Technologies (MRM) Japan $0.035B 0.00
Ontrak (OTRK) United States $0.002B 0.00
Psychemedics (PMD) United States $0.000B 0.00